GRCL - Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.07
2023-03-13 07:41:15 ET
- Gracell Biotechnologies press release ( NASDAQ: GRCL ): Q4 GAAP EPS of -$0.06 beats by $0.07 .
-
As of December 31, 2022, the Company had RMB1,458.2 million (US$211.4 million) in cash and cash equivalents and short-term investments.
For further details see:
Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.07